Exicure (NASDAQ:XCUR) Posts Earnings Results

Exicure (NASDAQ:XCUR) released its quarterly earnings results on Tuesday. The company reported ($3.39) EPS for the quarter, Zacks reports.

Exicure Price Performance

NASDAQ XCUR opened at $12.77 on Thursday. The company’s 50 day simple moving average is $10.42 and its 200 day simple moving average is $9.41. Exicure has a 12 month low of $1.44 and a 12 month high of $36.00. The company has a market capitalization of $33.27 million, a P/E ratio of -6.17 and a beta of 3.84.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.